top of page
GrayMatters Health Header image

2 April 2025

Amygdala EFP Neurofeedback Effects on PTSD Symptom Clusters and Emotional Regulation Processes

​

/ Goldental N, Gross R, Amital D, Harel EV, Hendler T, Tendler A,  Levi L, Lavro D, Harmelech T, Grinapol S, Nacasch N, Fruchter E.
Journal of Clinical Medicine. 2025; 14(7):2421. 

 

Post-traumatic stress disorder (PTSD) manifests through distinct symptom clusters that can respond differently to treatments.

 

Self-neuromodulation guided by the Amygdala-derived EFP has been utilized to train PTSD patients to regulate amygdala-related activity and decrease symptoms. 
A combined analysis of 128 PTSD patients from three clinical trials of Amygdala-derived EFP self-neuromodulation was done to evaluate effects across symptom clusters (as assessed by CAPS-5 subscales) and on emotion regulation processing (evaluated by the ERQ). 


Amygdala-derived EFP self-neuromodulation significantly reduced severity across all PTSD symptom clusters immediately post-treatment, with improvements maintained at three-month follow-up. The arousal and reactivity cluster showed continued significant improvement during follow-up. Combined effect sizes were large (η2p = 0.23–0.35) across all symptom clusters. Regression analysis revealed that emotion regulation processes significantly explained 17% of the variance in symptom improvement during the follow-up period. 


Amygdala-derived EFP self-neuromodulation demonstrated a reduction of PTSD symptoms across all symptom clusters with benefits continuing after treatment completion.

​

To read the full article on Journal of Clinical Medicine - https://www.mdpi.com/2077-0383/14/7/2421 

GrayMatters Health logo

© 2025 GrayMatters Health. All Rights Reserved.

  • LinkedIn
  • Youtube

Disclaimer: The information on this website is not intended to be a substitute for professional medical advice. Always discuss treatment options and treatment outcomes with your physician or other qualified mental health provider.​

bottom of page